Skip to Content
Merck
CN

P4902

2-Phenylethyl β-D-thiogalactoside

≥98% (TLC)

Synonym(s):

PETG, Phenethyl β-D-thiogalactoside

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C14H20O5S
CAS Number:
Molecular Weight:
300.37
UNSPSC Code:
12352201
NACRES:
NA.25
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
20033
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥98% (TLC)

form

powder

optical activity

[α]/D -33.00 to -27.00°, c = 9.00-11.00 mg/mL in methanol

technique(s)

thin layer chromatography (TLC): suitable

color

white

solubility

methanol: 49.00-51.00 mg/mL, clear, colorless

storage temp.

2-8°C

SMILES string

OC[C@H]1O[C@@H](SCCc2ccccc2)[C@H](O)[C@@H](O)[C@H]1O

InChI

1S/C14H20O5S/c15-8-10-11(16)12(17)13(18)14(19-10)20-7-6-9-4-2-1-3-5-9/h1-5,10-18H,6-8H2/t10-,11+,12+,13-,14+/m1/s1

InChI key

ZNAMMSOYKPMPGC-HTOAHKCRSA-N

General description

2-Phenylethyl β-D-thiogalactoside is a cell-permable inhibitor of the reporter enzyme β-galactosidase.

Application

2-Phenylethyl β-D-thiogalactoside has been used in a study to assess subnanoliter enzymatic assays on microarrays. It has also been used in a study that investigated the integration of on-column immobilized enzyme reactor in microchip electrophoresis.

Other Notes

To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Kyung-Han Lee et al.
European journal of nuclear medicine and molecular imaging, 31(3), 433-438 (2004-01-28)
There has recently been increasing interest in the development of radioprobes that specifically target proteins transcribed from expression of reporter genes of interest. The purpose of this study was to develop a radioprobe that targets one of the most widely
Todd Galbraith et al.
Biotechnology journal, 14(1), e1800306-e1800306 (2018-11-30)
There is a strong clinical need to develop small-caliber tissue-engineered blood vessels for arterial bypass surgeries. Such substitutes can be engineered using the self-assembly approach in which cells produce their own extracellular matrix (ECM), creating a robust vessel without exogenous
Pranav R H Joshi et al.
Molecular therapy. Methods & clinical development, 13, 279-289 (2019-03-20)
Despite numerous advancements in production protocols, manufacturing AAV to meet exceptionally high demand (1016-1017 viral genomes [VGs]) in late clinical stages and for eventual systemic delivery poses significant challenges. Here, we report an efficient, simple, scalable, robust AAV5 production process



Global Trade Item Number

SKUGTIN
P4902-1G04061826061534
P4902-250MG04061832392493
P4902-50MG04061832392509